Production (Stage)
Fractyl Health, Inc.
GUTS
$2.17
-$0.10-4.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -23.74M | -24.97M | -23.17M | -17.23M | -3.32M |
| Total Depreciation and Amortization | 290.00K | 223.00K | 209.00K | 192.00K | 53.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 265.00K | 2.73M | 2.78M | -742.00K | -11.86M |
| Change in Net Operating Assets | -1.90M | 4.98M | 2.15M | -958.00K | 3.42M |
| Cash from Operations | -25.08M | -17.03M | -18.04M | -18.74M | -11.71M |
| Capital Expenditure | -448.00K | -233.00K | -213.00K | -260.00K | -1.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -448.00K | -233.00K | -213.00K | -260.00K | -1.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -109.00K | -106.00K | -58.00K | -21.00K | -2.00K |
| Issuance of Common Stock | 280.00K | 173.00K | 220.00K | 16.00K | 103.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -2.85M |
| Cash from Financing | 171.00K | 67.00K | 162.00K | -5.00K | 101.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.36M | -17.20M | -18.09M | -19.00M | 88.23M |